Mutual Non-Disclosure Agreement

Effective Date: ___________________________

1. Purpose

The Parties wish to evaluate a potential business relationship involving the licensing, integration, co-branding, or strategic use of the AI Stock Market Impacts analytical engine, associated methodologies, knowledge bases, and content assets (the “Purpose”). To facilitate this evaluation, each Party may disclose Confidential Information to the other.

2. Definition of Confidential Information

“Confidential Information” means any non-public information disclosed by either Party to the other, whether orally, in writing, electronically, or by demonstration, that relates to the disclosing Party’s business, technology, methodology, or intellectual property. For the Discloser, this includes but is not limited to:

1. The AI-Stocks scoring engine: algorithms, component weights, calibration parameters, cross-industry effect coefficients, CCVR profiles, time-gating mechanisms, and regulatory drag models;
2. The calibration methodology: source selection criteria, data grounding assessments, parameter adjustment rationale, and version-controlled changelog with specific numerical changes;
3. Knowledge base architecture: entry structure, dimensional tagging framework, freshness tracking, source authority ratings, and adoption mirage correction methods;
4. Source intelligence: the identity, frequency, priority ranking, and processing rules for tracked institutional report sources;
5. Unpublished analysis, draft reports, subscriber data, revenue figures, and business strategy;
6. Any derivative analysis, scoring output, or content generated using the above.

Confidential Information does not include information that: (i) is or becomes publicly available through no fault of the Recipient; (ii) was known to the Recipient prior to disclosure, as demonstrated by written records; (iii) is independently developed by the Recipient without reference to the Confidential Information; or (iv) is disclosed to the Recipient by a third party not bound by confidentiality obligations to the Discloser.

3. Obligations

1. Each Party shall use Confidential Information solely for the Purpose stated in Section 1.
2. Each Party shall protect Confidential Information using at least the same degree of care it uses to protect its own confidential information of similar importance, but in no event less than reasonable care.
3. Disclosure of Confidential Information is limited to the Recipient’s employees, contractors, or advisors who (a) have a need to know for the Purpose, and (b) are bound by confidentiality obligations no less restrictive than those in this Agreement.
4. Neither Party shall disclose the existence or terms of this Agreement, or the nature of the discussions, to any third party without the prior written consent of the other Party, except as required by law.

4. Prohibition on Reverse Engineering and Derivation

The Recipient shall not reverse engineer, decompile, deconstruct, or attempt to derive the underlying methodology, algorithms, coefficients, or data structures of the Discloser’s analytical engine or knowledge bases. The Recipient shall not develop, or cause to be developed, any substantially similar analytical system based on information obtained under this Agreement.

5. No License or Obligation

Nothing in this Agreement grants either Party any license, right, or interest in the other Party’s Confidential Information, intellectual property, patents, copyrights, or trade secrets beyond the limited right to evaluate the information for the Purpose. Neither Party is obligated to enter into any further agreement, license, or business relationship as a result of this Agreement.

6. Compelled Disclosure

If the Recipient is compelled by law, regulation, or legal process to disclose Confidential Information, the Recipient shall: (a) provide prompt written notice to the Discloser, to the extent legally permitted, to allow the Discloser to seek a protective order; and (b) disclose only the minimum information legally required.

7. Term and Duration

1. Capture Period: This Agreement covers Confidential Information disclosed during the 18-month period beginning on the Effective Date.
2. Confidentiality Term: The obligations in this Agreement survive for 3 years following the end of the Capture Period, or 3 years following the date of each specific disclosure, whichever is longer.
3. Either Party may terminate this Agreement with 30 days’ written notice, but termination does not affect obligations regarding Confidential Information already disclosed.

8. Return or Destruction of Materials

Upon termination of this Agreement, or upon written request by the Discloser, the Recipient shall promptly return or destroy all Confidential Information in its possession, including copies, notes, and derivative materials, and shall certify in writing that it has done so. Exceptions: (a) one archival copy may be retained by Recipient’s legal counsel solely for compliance verification; (b) copies contained in automated backup systems may be retained until the normal expiration of those backups, subject to continued confidentiality obligations.

9. Remedies

Each Party acknowledges that unauthorized disclosure of Confidential Information may cause irreparable harm for which monetary damages may be an inadequate remedy. Accordingly, each Party is entitled to seek injunctive or other equitable relief in addition to any other remedies available at law or in equity, without the requirement of posting a bond.

10. General Provisions

1. Governing Law: This Agreement is governed by the laws of the Province of Ontario, Canada, without regard to conflict of laws principles.
2. Entire Agreement: This Agreement constitutes the entire agreement between the Parties regarding confidentiality of the subject matter and supersedes all prior discussions, understandings, or agreements.
3. Amendment: This Agreement may only be modified by a written instrument signed by both Parties.
4. Severability: If any provision is found unenforceable, the remaining provisions remain in full force and effect.
5. Assignment: Neither Party may assign this Agreement without the prior written consent of the other Party.
6. Counterparts: This Agreement may be executed in counterparts, including electronic signatures, each of which shall be deemed an original.

The following is a summary of the analytical engine’s architecture, provided for evaluation purposes under the terms of this Agreement. Detailed parameter values, coefficients, and calibration specifics are available upon execution of this NDA and mutual agreement to proceed with evaluation.

AI Stock Market Impacts • scovert.com • [email protected]
Methodology NDA — Version 1.0 — April 2026